Tag: Cancer: Skin
Pembrolizumab Active in Patients With Advanced Melanoma
Overall response rate of 33 percent for total population, 45 percent among treatment naive
AACR: Pembrolizumab Effective Against Merkel-Cell Carcinoma
Intravenous medication blocks programmed death 1 (PD-1) immune inhibitory pathway
AACR: Nivolumab Appears to Up Survival in Advanced Melanoma
One-third of study participants lived five years or more after starting treatment
Oral Nicotinamide Safe for Renal Transplant Recipients
Treatment linked to nonsignificant reductions in new non-melanoma skin cancers
AACR: SPF 30 Delays Melanoma in Preclinical Model
Study results suggest scientists can use mice to find better ways to prevent melanoma in humans
Excision Margins Don’t Impact Melanoma Recurrence, Survival
Although, sentinel lymph node involvement is tied to poor prognosis
Considerable Agreement on Presence of BCC on Mohs Slides
Slides scored as difficult to diagnose independent risk factor for interpersonal discordant diagnosis
MC1R Variants May Up Melanoma Risk, Even Without Sun Exposure
Variant of gene linked to skin pigmentation tied to higher risk
Poor Prognosis for Women With Pregnancy-Associated Melanoma
Among women aged up to 49 years, invasive melanoma less common in those 19 years or younger
Non-HIV-Related Kaposi Sarcoma in BRAFi-Treated Patient
Patient with history of myasthenia gravis, metastatic melanoma presented with macules on both feet
